Rick Staelin, Chairman of the Board, BioElectronics Corporation (BIEL) called in to SmallCapVoice.com, Inc. to go over his Company’s explosive sales growth and the drivers behind that growth. In BIEL’s last quarter they reported 216% increase in sales over the same quarter a year ago ($ 499,869 versus $231,174) . For the nine months ending September 30 they’re up 248 percent ($1,678,665 versus $677,454). BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.